ITDOSE INFOSYSTEMS PVT. LTD.

NAME :Miss. KHUSHBOO AGGARWAL

AGE/GENDER :21 Y/Female SPECIMEN DATE :12/Apr/2024 10:26AM
TEST REQUEST ID :012404120041 SPECIMEN RECEIVED :12/Apr/2024 10:32AM
REFERRED BY :Self REPORT DATE :12/Apr/2024 04:00PM

Test Name Result Ref. Range Unit

PCOD ASSESSMENT PANEL

BIOCHEMISTRY
BLOOD SUGAR FASTING
Blood Sugar Fasting 86.6 70 - 110 mg/dL
Method:GOD/PAP

Page 1 of 5
ITDOSE INFOSYSTEMS PVT. LTD.

NAME :Miss. KHUSHBOO AGGARWAL

AGE/GENDER :21 Y/Female SPECIMEN DATE :12/Apr/2024 10:26AM
TEST REQUEST ID :012404120041 SPECIMEN RECEIVED :12/Apr/2024 10:32AM
REFERRED BY :Self REPORT DATE :12/Apr/2024 05:24PM

Test Name Result Ref. Range Unit

IMMUNOASSAY
T3 (TRI- IODOTHYRONINE)
T3 (Tri-Iodothyronine) 1.340 0.87 - 1.78 ng/mL
Method:Electrochemiluminescence Immunoassay

T4 (THYROXINE)
Thyroxine Total [T4] 11.250 6.09 - 12.23 µg/dL
Method:Electrochemiluminescence Immunoassay

TSH
TSH (Thyroid Stimulating Hormone) 2.271 µIU/mL
Method:Electrochemiluminescence Immunoassay

Reference Range - Age Related

TSH (µIU/mL)
Cord blood : 1.0 - 17.4
1 - 14 days : 1.0 - 39.0
2 - 20 weeks : 1.7 - 9.1
5 - 24 months : 0.8 - 8.2
2 - 21 years : 0.7 - 5.7
Adults (>21 years) : 0.38 - 5.33
Reference Range - Pregnancy
st
1 Trimester : 0.05 - 3.7
2 nd Trimester : 0.31 - 4.35
3 rd Trimester : 0.41 - 5.18

Interpretation:

The TSH levels are inversely related to T3 & T4 levels. In primary hypothyroidism, TSH levels are high while T3 & T4 levels are low. Whereas in primary
hyperthyroidism, TSH levels are low with high T3 & T4 levels. A low T3 & T4 in the presence of low or normal TSH indicates hypothalamic or pituitary dysfunction.
A high TSH in the presence of normal or high T4 suggests inappropriate TSH secretion. INCREASED LEVELS are seen in primary hypothyroidism, inappropriate
TSH secretion, systemic illness, rarely in TSH secreting pituitary tumors (Secondary hyperthyroidism). DECREASED LEVELS are seen in secondary hypothyroidism,
hyperthyroidism.

Sample Type: Serum

Instrument: Beckman Coulter Access 2 Fully Automated Immunoassay Analyser

FSH-LH-PROLACTIN

Page 2 of 5
NAME :Miss. KHUSHBOO AGGARWAL
AGE/GENDER :21 Y/Female SPECIMEN DATE :12/Apr/2024 10:26AM
TEST REQUEST ID :012404120041 SPECIMEN RECEIVED :12/Apr/2024 10:32AM
REFERRED BY :Self REPORT DATE :12/Apr/2024 05:24PM

Test Name Result Ref. Range Unit

Follicle Stimulating Hormone(FSH) 7.270 Women mlU/mL
Follicular phase: 3.5 - 12.5
Method:Electrochemiluminescence Immunoassay
Ovulation phase: 4.7 - 21.5
Luteal phase: 1.7 - 7.7
Postmenopause: 25.8 - 134.8
Men: 1.5 - 12.4

Interpretation:

A glycoprotein produced by the anterior pituitary gland and its production is regulated by GnRH. In females FSH stimulate follicular growth, prepares ovarian follicles
for the action of LH & enhance LH induced release of estrogens. In males, FSH stimulated semniferous tubles & testicular growth & is involved in the early stages of
spermatogenesis. Thus FSH is used in the diagnosis of gonadal functions disorder. High levels are same in primary hypogonadism including primary testicular failure,
gonadotropin secreting pituitary tumours, and menopause. Low levels are seen in hypothalamic GnRH deficiency, pituitary FSH deficiency & ectopic steriod hormone
production. INCREASED LEVELS are seen in primary hypogonadism, gonadotropin secreting pituitary tumours, menopause. DECREASED LEVELS are seen in
hypothalamic gonadotropin releasing hormone deficiency, pituitary FSH deficiency, ectopic steroid hormone production.

Sample Type: Serum

Instrument: Beckman Coulter Access 2 Fully Automated Immunoassay Analyser

Luteinizing Hormone (LH) 19.090 Women mIU/mL

Follicular phase: 2.12 - 10.89
Method:Electrochemiluminescence Immunoassay
Ovulation phase: 19.2 - 103.0
Luteal phase: 1.2 - 12.8
Postmenopause: 10.8 - 58.5
Men: 1.24 - 8.6

Interpretation:

Human luteinizing hormone (LH) is a glycoprotein hormone secreted by the anterior pituitary gland. LH, FSH & other steroid hormones play important roles in
regulating the ovulation & ovarian functions during the menstural cycle. Maturation of an ovarian follicle & its oocyte begins during the end of the preceding menstural
cycle. When FSH is released by the pituitary gland, the ovarian follicle undergoes rapid growth. As it develops, estradiol secretion slowly increases. Immediately prior to
& during the LH surge, estradiol secretion rapidly increases. This rapid increase is generally believed to trigger the rapid rise & peaking of LH activity at mid-cycle, the
LH surge. Ovulation beings twelve to twenty-four hours after the LH surge. The wall of the enlarged follicle ruptures & the mature ovum is extruded. Within two days
the LH concentration returns to its baseline level. A concomitant rise in progesterone level intimates the luteal phase which lasts approximately fourteen days. during
this time, if the mature ovum is not fertilized, a new follicle enters the maturation route marking the begining of the next menstural cycle. In light of the characteristic
fluctuation of LH levels during the menstural cycle, rapid & sensitive detection of LH is useful in the diagnosis & treatment of infertility & in the detection of the LH
surge to predict the time of ovulation. As the onset of the LH surge precedes ovulation by approximately thirty hours, its determination has been used successfully to
time oocyte retrieval for in vitro fertilization & to assist in the timing of artificial insemination.

INCREASED LEVELS are seen in luteal phase of menstural cycle, primary hypogonadism, gonadotropin secreting pituitary tumours, menopause. DECREASED
LEVELS are seen in hypothalamic gonadotropin releasing hormone deficiency, pitutary LH deficiency, ectopic steroid hormone production, gonadotropin releasing
hormone analog treatment.

Page 3 of 5
NAME :Miss. KHUSHBOO AGGARWAL
AGE/GENDER :21 Y/Female SPECIMEN DATE :12/Apr/2024 10:26AM
TEST REQUEST ID :012404120041 SPECIMEN RECEIVED :12/Apr/2024 10:32AM
REFERRED BY :Self REPORT DATE :12/Apr/2024 05:24PM

Test Name Result Ref. Range Unit

Sample type: Serum
Instrument: Beckman Coulter Access 2 Fully Automated Immunoassay Analyser
Prolactin 22.540 Female ng/mL
Not pregnant: 4.79 - 23.3
Method:Electrochemiluminescence Immunoassay
Menopausal phase: 5.0 - 35.0
Male: 4.04 - 15.2

Interpretation:

Human prolactin (h PRL or lactogenic hormone), is a single chain polypeptide with a molecular weight of approximately 22,000 secreted from the anterior pituitary.
Women normally have slightly high basal prolactin levels than men, there is apparently an estrogen-related rise at puberty and a corresponding decrease at menopause.
During the pregnancy, prolactin levels increase to between 10-20 times normal values, declining to non-pregnant levels by 3-4 weeks postpartum. Breast feeding
mothers maintain higher levels of prolactin for several months. Concentrations may also be raised by drugs such as chloropromazine, reserpine and estrogen and lowered
by bromocyptine and I - dopa measurment of prolactine is helpful in the diagnosis of amenorrohea and hypothalmic pituitary disorders.

INCREASED LEVELS are seen in pituitary tumour (Prolactinoma, section of pituitary stalk, 20-40% patients with acromegaly and upto 80% of patients with
chromophobe adenoma), Amenorrhoea, Polycystic ovarian disease, o-pills, Hypothalamic lesions, Sarcoidosis, Tuberculosis, Glioma, Hypothyroidism, Anti-depressants,
Breast feeding, Stress. DECREASED LEVELS are seen in bromocryptine (Dopamine agonist).

PHYSIOLOGICAL FACTORS INCREASING PROLACTIN SECRETION are seen in pregnancy, post-partum loctation, sleep, breast stimulation in women, emotional
or physical stress, Hypoglycemia, sexual intercourse in women, strenous exercise, drugs-tranquilisers and antidepressants like phenothiazines and tricyclics,
metoclopramide, diurnal variation-levels highest at night during sleep.

Sample Type: Serum

Instrument: Beckman Coulter Access 2 Fully Automated Immunoassay Analyser

TESTOSTERONE - TOTAL
Testosterone-Total 1.10 ng/mL

Normal Range:
Male
Premature (26 - 28 wks): 0.59 - 1.25 ng/mL
Premature (31 - 35 wks): 0.37 - 1.98 ng/mL
Newborn : 0.75 - 4.00 ng/mL
1 - 7 days : 0.20 - 0.50 ng/mL
20 - 60 days : 60.0 - 400.0 ng/mL
Near 7 months : 3.0 - 10.0 ng/mL
7 - 9 yrs : < 0.09 ng/mL
10 - 11 yrs : 0.02 - 0.57 ng/mL
12 - 13 yrs : 0.07 - 7.47 ng/mL
14 - 15 yrs : 0.33 - 5.85 ng/mL
16 - 18 yrs : 1.88 - 8.82 ng/mL

Page 4 of 5
NAME :Miss. KHUSHBOO AGGARWAL
AGE/GENDER :21 Y/Female SPECIMEN DATE :12/Apr/2024 10:26AM
TEST REQUEST ID :012404120041 SPECIMEN RECEIVED :12/Apr/2024 10:32AM
REFERRED BY :Self REPORT DATE :12/Apr/2024 05:24PM

Test Name Result Ref. Range Unit

19 - 49 yrs : 2.49 - 8.36 ng/mL
> 50 yrs : 1.93 - 7.40 ng/mL
Female
Ovulating : 0.084 - 0.481 ng/mL
Post Manopausal : 0.029 - 0.408 ng/mL

Interpretation:

In males, the testosterone assay can be used as an aid in the differential diagnosis of hypogonadism, hypopituitarism and hyperprolactinemia, as well as monitoring of
anti-androgen and testosterone replacement therapy. Elevated total testosterone values in males can be caused by exogenous testosterone use, congenital adrenal
hyperplasia or disorders of the hypothalamic-pituitary-testicular axis. In females, the assay may be used in the evaluation of hyperandrogenism, congenital adrenal
hyperplasia and other disorders of the hypothalamic-pituitary-testicular axis.

Testosterone in males is secreted by adult Leydig cells and is controlled principally by luteinizing hormone (LH). The majority of serum testosterone is bound to
albumin and in the free state. In females, testosterone is produced in the ovaries, adrenal gland, and peripheral fatty tissue.

Sample Type: Serum

Instrument: Beckman Coulter Access 2 Fully Automated Immunoassay Analyser

INSULIN (FASTING)
Insulin fasting 11.00 3.0 - 22.0 µIU/mL
Method:ECLIA

Interpretation:

Insulin is released in response to the presence of glucose in the blood typically after the ingestion of a meal. Insulin levels can be useful in evaluating patients with
fasting hypoglycemia, in determining insulin resistance in the general population, and in assessing abnormalities in beta cell secretory function. Insulin levels are used in
studying the pathophysiology of diabetes.

Sample Type: Serum

Instrument: Backman Coulter Access 2 Fully Automated Immunoassay Analyser

-----End Of Report-----

Page 5 of 5